162 related articles for article (PubMed ID: 24774475)
1. Evidence, values, and decision making.
Rawlins MD
Int J Technol Assess Health Care; 2014 Apr; 30(2):233-8. PubMed ID: 24774475
[TBL] [Abstract][Full Text] [Related]
2. SCIENTIFIC AND SOCIAL VALUE JUDGMENTS FOR ORPHAN DRUGS IN HEALTH TECHNOLOGY ASSESSMENT.
Nicod E; Kanavos P
Int J Technol Assess Health Care; 2016 Jan; 32(4):218-232. PubMed ID: 27624559
[TBL] [Abstract][Full Text] [Related]
3. Revealing and acknowledging value judgments in health technology assessment.
Hofmann B; Cleemput I; Bond K; Krones T; Droste S; Sacchini D; Oortwijn W
Int J Technol Assess Health Care; 2014 Dec; 30(6):579-86. PubMed ID: 25816823
[TBL] [Abstract][Full Text] [Related]
4. Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis.
Eddy D
Health Aff (Millwood); 2007; 26(4):w500-15. PubMed ID: 17580317
[TBL] [Abstract][Full Text] [Related]
5. The Role of Noncomparative Evidence in Health Technology Assessment Decisions.
Griffiths EA; Macaulay R; Vadlamudi NK; Uddin J; Samuels ER
Value Health; 2017 Dec; 20(10):1245-1251. PubMed ID: 29241883
[TBL] [Abstract][Full Text] [Related]
6. Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes.
Baltussen R; Jansen MPM; Bijlmakers L; Grutters J; Kluytmans A; Reuzel RP; Tummers M; der Wilt GJV
Value Health; 2017 Feb; 20(2):256-260. PubMed ID: 28237205
[TBL] [Abstract][Full Text] [Related]
7. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
8. Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries.
Visintin E; Tinelli M; Kanavos P
Health Policy; 2019 Feb; 123(2):118-129. PubMed ID: 30227974
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based decision-making 3: Health technology assessment.
O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
[TBL] [Abstract][Full Text] [Related]
10. National Institute for Clinical Excellence (NICE). HTA rhyme and reason?
Taylor R
Int J Technol Assess Health Care; 2002; 18(2):166-70. PubMed ID: 12053416
[TBL] [Abstract][Full Text] [Related]
11. ETHICS IN HEALTH TECHNOLOGY ASSESSMENT: A SYSTEMATIC REVIEW.
Bellemare CA; Dagenais P; K-Bédard S; Béland JP; Bernier L; Daniel CÉ; Gagnon H; Legault GA; Parent M; Patenaude J
Int J Technol Assess Health Care; 2018 Jan; 34(5):447-457. PubMed ID: 30296950
[TBL] [Abstract][Full Text] [Related]
12. Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.
Xie F; Bowen JM; Sutherland SC; Burke N; Blackhouse G; Tarride JE; O'Reilly D; Goeree R
Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):513-21. PubMed ID: 21958096
[TBL] [Abstract][Full Text] [Related]
13. Methodological issues in undertaking independent cost-effectiveness analysis for NICE: the case of therapies for ADHD.
Griffin SC; Weatherly HL; Richardson GA; Drummond MF
Eur J Health Econ; 2008 May; 9(2):137-45. PubMed ID: 17476538
[TBL] [Abstract][Full Text] [Related]
14. Identification and review of cost-effectiveness model parameters: a qualitative study.
Kaltenthaler E; Essat M; Tappenden P; Paisley S
Int J Technol Assess Health Care; 2014 Jul; 30(3):333-40. PubMed ID: 25089856
[TBL] [Abstract][Full Text] [Related]
15. Public preferences for engagement in Health Technology Assessment decision-making: protocol of a mixed methods study.
Wortley S; Tong A; Lancsar E; Salkeld G; Howard K
BMC Med Inform Decis Mak; 2015 Jul; 15():52. PubMed ID: 26166149
[TBL] [Abstract][Full Text] [Related]
16. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
[TBL] [Abstract][Full Text] [Related]
17. Health Technology Assessment-Informed Decision Making by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care in Germany and the National Institute for Health and Care Excellence in England: The Role of Budget Impact.
Schaefer R; Hernández D; Bärnighausen T; Kolominsky-Rabas P; Schlander M
Value Health; 2023 Jul; 26(7):1032-1044. PubMed ID: 36921901
[TBL] [Abstract][Full Text] [Related]
18. Application of HTA research on policy decision-making.
Youngkong S
J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
[TBL] [Abstract][Full Text] [Related]
19. Social and ethical analysis in health technology assessment.
Tantivess S
J Med Assoc Thai; 2014 May; 97 Suppl 5():S81-6. PubMed ID: 24964703
[TBL] [Abstract][Full Text] [Related]
20. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
